Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma

Haematologica. 2014 Sep;99(9):e162-4. doi: 10.3324/haematol.2014.110395. Epub 2014 Jun 27.

¹ University of Chicago, Chicago, IL, USA University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA Karol Marcinkowski University of Medical Sciences, Poznan, Poland.
² University of Chicago, Chicago, IL, USA.
³ University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.
⁴ The John Theurer Cancer Center at Hackensack UMC, Hackensack, NJ, USA.
⁵ Mount Sinai Medical Center, New York, NY, USA.
⁶ Washington University School of Medicine, St. Louis, MO, USA.
⁷ University of Chicago, Chicago, IL, USA University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA [email protected].

No abstract available

Keywords: carfilzomib; elderly; lenalidomide; low-dose dexamethasone; multiple myeloma; newly diagnosed.

Publication types